NCT07853261

Brief Summary

This is a prospective, single-center, single-arm exploratory observational study aiming to evaluate the impact of stepwise pressure-increasing non-compliant (NC) balloon post-dilation on stent expansion rate in patients undergoing single-stent implantation for coronary artery stenosis, with stent sizing guided by intravascular ultrasound-external elastic membrane (IVUS-EEM) measurement. A total of 150 eligible patients will be enrolled at The First Hospital of Jilin University. All participants will receive standard single-stent implantation followed by multi-stage stepwise pressure-increasing NC balloon post-dilation under IVUS monitoring. The post-dilation protocol includes sequential inflation at nominal pressure, rated burst pressure, and 24 atm, with IVUS assessment performed after each stage. All treatment procedures are conducted in accordance with routine clinical practice; no additional randomization or mandatory intervention is applied beyond the standard of care. The study solely observes and records outcomes associated with this treatment strategy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for not_applicable coronary-artery-disease

Timeline
3mo left

Started Jan 2026

Shorter than P25 for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Jan 2026Dec 2026

Study Start

First participant enrolled

January 7, 2026

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 23, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 1, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

October 1, 2026

Status Verified

September 1, 2026

Enrollment Period

12 months

First QC Date

September 23, 2026

Last Update Submit

September 28, 2026

Conditions

Keywords

coronary artery diseasestentpost dilationstent expansion

Outcome Measures

Primary Outcomes (1)

  • Minimum Stent Area (MSA)

    IVUS-measured minimum lumen cross-sectional area within the stented segment post-procedure (after stent deployment with norminal pressure, 12\*10 atm, 18\*10 atm and 24\*10 atm NC balloon post-dilation), Final post-dilation will be attempted at 24 atm for up to 120 seconds, with the duration limited to the patient's maximum tolerated time if premature intolerance occurs.

    3 days

Study Arms (1)

Serial pressure dilation

EXPERIMENTAL

After stent nominal pressure deployment stent will be postdilated at 12atm\*10s, 18atm \*10s, 24atm\*10s.Final post-dilation will be attempted at 24 atm for up to 120 seconds, with the duration limited to the patient's maximum tolerated time if premature intolerance occurs.IVUS measurement will be done after each dilation for the MSA and stent expansion

Device: Coronary stent + non-compliant post-dilation balloon

Interventions

Coronary stent implantation followed by serial pressure post-dilation using non-compliant balloon under IVUS guidance

Serial pressure dilation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years regardless of gender;
  • Coronary angiography confirms single-vessel coronary artery stenosis ≥50%, meeting the indication for single-stent implantation;
  • Preoperative IVUS examination can clearly visualize the vessel EEM, allowing for stent size measurement and assessment of stent expansion-related parameters;
  • The patient voluntarily participates in this study and signs the informed consent form;
  • No contraindications related to IVUS examination, stent implantation, or balloon angioplasty.

You may not qualify if:

  • Hemodynamically unstable
  • Presence of anatomical or pathological factors preventing IVUS catheter crossing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Hospital of Jilin University

Changchun, Jilin, 130000, China

RECRUITING

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Central Study Contacts

Mingyou Zhang, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 23, 2026

First Posted

October 1, 2026

Study Start

January 7, 2026

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

October 1, 2026

Record last verified: 2026-09

Locations